Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2020 | Limitations of pharmacological and surgical treatment for motor fluctuations in Parkinson’s disease

Joaquim Ferreira • 4 Sep 2020
MDS 2020
Movement Disorders Parkinson's Disease Opicapone

Joaquim Ferreira, MD, PhD, Faculty of Medicine, University of Lisbon, Lisbon, Portugal, discusses how despite new developments in pharmacological treatment for Parkinson’s, there is still no cure. The disease still occurs and is unavoidable. Therefore, we need to invest in continued research to improve upon our current treatments. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Joaquim Ferreira

1:43
Update on the ADOPTION study: opicapone in Parkinson’s disease
Joaquim Ferreira • 29 Aug 2023
1:19
Combining non-pharmacological treatments with pharmacotherapies for PD
Joaquim Ferreira • 29 Aug 2023
1:49
How dose and regimen impact levodopa bioavailability
Joaquim Ferreira • 29 Aug 2023
2:24
The importance of clinical trials in generating evidence for safe and effective therapies
Joaquim Ferreira • 29 Aug 2023

Related Videos

1:19
The potential of cell and gene therapy in treating Parkinson’s disease
Fabrizio Stocchi • 7 Mar 2024
4:11
Updates on current Parkinson’s disease clinical trials
Fabrizio Stocchi • 7 Mar 2024
3:42
NfL shows strong prognostic value in pre-manifest Huntington's disease
Natalia E. Owen • 8 Mar 2024
5:26
Pridopidine shows benefit for patients with early HD not on antidopaminergic therapies
Michael Hayden • 16 Apr 2024
The content of VJNeurology is intended for healthcare professionals